Bio Key International (BKYI) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider trades in the last 12 months.
Label: Quiet · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Purchase Michael W. Depasquale, CEO bought 1,986 shares at $1.91 ($4K).
- Trade date
- Nov 17, 2026
- Disclosed to the SEC
- Nov 19, 2026
- Type
- Open-market purchase (code P)
Michael W. Depasquale's record since 2020: 1 of 3 past buys beat the S&P 500 over 90 days (small sample).
Read the original SEC filing ↗All BKYI insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
BKYI insider transactions (Form 4)
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 19SEC | Michael W. DepasqualeCEOFirst buy in 3 yrsPast buys 1/3 beat S&P | Buy | 1,98612,764 held (+18%) | $1.91 | $4K | — | — |
Similar past setups: not applicable. BKYI has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with BKYI in the Research Lab
BKYI has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Price history unavailable.
Bio Key International insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 0 sold $0 of BKYI stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
BKYI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $4K | 1 | — | 0 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 20, 2026. Volume and paper profit use daily closing prices.
Summary
No open-market purchases or sales by BIO KEY INTERNATIONAL INC insiders were reported in the past 12 months.
BKYI stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insiders at BIO KEY INTERNATIONAL INC
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Michael W. DepasqualeCEO | $4K | — | Nov 19, 2026 | 1 of 3 | — |
Insider activity at other Industrials companies
Same sector, ranked by insider buying in the last 90 days.
BKYI stock: common questions
Are BIO KEY INTERNATIONAL INC insiders buying BKYI stock?
No. No BIO KEY INTERNATIONAL INC insider reported an open-market purchase of BKYI in the past 12 months. The latest was CEO Michael W Depasquale bought $4K of BKYI at $1.91 — first open-market purchase in our records.
Are BIO KEY INTERNATIONAL INC insiders selling BKYI stock?
No. No BIO KEY INTERNATIONAL INC insider reported an open-market sale of BKYI in the past 12 months.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.